The aim of the CU-CSU Summit is to engage researchers at all levels of training from each CCTSI partner institution – CU Anschutz, CU Denver, CU Boulder and Colorado State University – who are interested in learning more about research resources, analysis and collaborations on the topic of the Evolving Impacts of COVID-19: Research Advances in Colorado and Beyond.
With this annual conference, the CCTSI seeks to foster new collaborations and innovative research across campuses.
When the pandemic hit last year, the CCTSI responded by creating the COVID-19-Rapid Research Pilot Program. Fifty-five people applied and the CCTSI chose four awardees. More than one year later, read about what they learned.
As Colorado surpasses a 47 percent rate of its population being fully immunized (with 12 counties surpassing 70 percent), researchers continue to expand the study of the vaccines on children as young as five years old. The CCTSI's Pediatric Clinical and Translational Research Center (CTRC) is playing a major role as it conducts the Pfizer BioNTech COVID-19 vaccine trial for children ages 5 - 11.